| Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in ... - PR Newswire (press release) |
|
|
PR Newswire (press release)Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy. The controlled, randomized trial of patients on ... read more |